Interferon-alpha Treatment of Chronic Cough in Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis
Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether lozenges containing interferon-alpha can
reduce the frequency and severity of coughing in patients with chronic obstructive pulmonary
disease (COPD) and idiopathic pulmonary fibrosis (IPF).